Privia Health Group (NASDAQ:PRVA – Get Free Report) is projected to announce its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect Privia Health Group to announce earnings of $0.0905 per share and revenue of $610.72 million for the quarter. Individuals can find conference call details on the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:00 AM ET.
Privia Health Group (NASDAQ:PRVA – Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.19 earnings per share for the quarter, topping the consensus estimate of $0.07 by $0.12. Privia Health Group had a return on equity of 3.52% and a net margin of 1.19%. The business had revenue of $632.63 million during the quarter, compared to analysts’ expectations of $597.33 million. During the same quarter last year, the business posted $0.24 EPS. The business’s revenue was up 21.4% on a year-over-year basis. On average, analysts expect Privia Health Group to post $0.27 EPS for the current fiscal year and $0.41 EPS for the next fiscal year.
Privia Health Group Stock Performance
PRVA opened at $21.47 on Wednesday. Privia Health Group has a 52-week low of $18.92 and a 52-week high of $28.82. The stock has a market capitalization of $2.74 billion, a PE ratio of 102.24 and a beta of 0.76. The stock’s 50 day moving average price is $20.89 and its 200-day moving average price is $22.64.
Wall Street Analysts Forecast Growth
Several brokerages have commented on PRVA. Weiss Ratings restated a “hold (c)” rating on shares of Privia Health Group in a report on Tuesday, September 29th. Zacks Research raised shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a research note on Wednesday, August 5th. Canaccord Genuity Group set a $32.00 price target on shares of Privia Health Group in a research report on Friday, August 7th. Finally, Citigroup reissued a “buy” rating on shares of Privia Health Group in a research note on Thursday, July 23rd. Eleven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $31.00.
View Our Latest Stock Analysis on Privia Health Group
About Privia Health Group
Privia Health Group, Inc is a physician-enablement company that partners with independent medical practices to support the delivery of coordinated, value-based care. The company provides an integrated platform designed to help physicians manage clinical, administrative and financial functions while maintaining ownership and control of their practices.
Its services include practice management, electronic health record and technology support, revenue-cycle management, payer contracting, population-health analytics, care-management programs and administrative assistance.
Read More
- Five stocks we like better than Privia Health Group
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
